Most Recent Additions*
EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS PREVIOUSLY TREATED WITH FIBRATES OR OBETICHOLIC ACID
Alejandra M. Villamil, Daniel Pratt, Andreas E. Kremer, Vincenza Calvaruso, Elena G. Dominguez, Louise Missen, Xin Qi, Sarah Proehl, William T. Barchuk, Timothy R. Watkins, and Stuart C. Gordon
TCT-739 Left Atrial Appendage Closure in Patients with Dementia: Data from The National Inpatient Sample Database
Diana Kailouh, Mohammad A. Sheffeh, Judy Sheffeh, Joud Fahed, Shehroze Tabassum, and M. Chadi Alraies
TCT-747 Sex and Racial Disparities in Patients Undergoing Left Atrial Appendage Closure in The United States – A Nationwide Analysis between 2018 to 2021
Diana Kailouh, Mohammad A. Sheffeh, Judy Sheffeh, Joud Fahed, Shehroze Tabassum, and M. Chadi Alraies
SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WITH CIRRHOSIS AND CLINICAL SIGNS OF PORTAL HYPERTENSION: DATA FROM THE ENHANCE AND RESPONSE STUDIES
Aliya Gulamhusein, Michael K. Porayko, Andrea Galli, Francesca Carubbi, Louise Missen, Xin Qi, Sarah Proehl, Daria B. Crittenden, and Stuart C. Gordon
EFFICACY AND SAFETY OF SELADELPAR AS MONOTHERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INTOLERANCE TO URSODEOXYCHOLIC ACID
Stuart C. Gordon, Guy Neff, Manuel Rodriguez, Ira M. Jacobson, Marlyn J. Mayo, Leena Sathia, Xin Qi, Sarah Proehl, Susheela Carroll, Daria B. Crittenden, and Aliya Gulamhusein
Multicentre international evaluation of autoimmune hepatitis and liver transplantation: disease recurrence is associated with recipient features, type of immunosuppression and impaired outcomes
Aldo J. Montano-Loza, Vincenzo Ronca, Maryam Ebadi, Bettina Hansen, Gideon Hirschfield, Saleh Elwir, Mohamad Alsaed, Piotr Milkiewicz, Maciej K. Janik, Hanns-Ulrich Marschall, Maria A. Burza, Cumali Efe, Ali R. Caliskan, Murat Harputluoglu, Gökhan Kabaçam, Debora R. Terrabuio, Fernanda Onofrio, Albert Pares, Laura P. Llovet, Murat Akyildiz, Cigdem Arıkan, Michael P. Manns, Richard Taubert, Anna-Lena Weber, Thomas Schiano, Brandy Hayde, Piotr Czubkowski, Piotr Socha, Natalia Ołdak, and Nobuhisa Akamatsu
Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment
Man-Fung Yuen, Jeong Heo, Ronald G. Nahass, Grace Lai-Hung Wong, Tatiana Burda, Kalyan R. Bhamidimarri, Tsung-Hui Hu, Tuan T. Nguyen, Young-Suk Lim, Chi-Yi Chen, Stuart C. Gordon, Jacinta Holmes, Wan-Long Chuang, Anita Kohli, Naim Alkhouri, Kevin Gray, Emily P. Thi, Elina Medvedeva, Timothy Eley, Sharie C. Ganchua, Christina Iott, Elizabeth Eill, Christine L. Espiritu, Mark Anderson, Tiffany Fortney, Gavin Cloherty, and Karen D. Sims
Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed CHB patients with moderate or severe renal impairment or ESRD on HD: final week 96 efficacy and safety results from a phase 2 study
Jeong Heo, Claire Fournier, Sang H. Ahn, Tak Y. O Tsang, Carla S. Coffin, Yi-Hsiang Huang, Giulio M. Reggiani, Aric J. Hui, Magdy Elkhashab, Chi-Yi Chen, Syed-Mohammed Jafri, Susanna Tan, Yang Zhao, Vithika Suri, John F. Flaherty, Anuj Gaggar, Diana Brainard, Wan-Long Chuang, Kosh Agarwal, Edward Gane, and Young-Suk Lim
Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Zobair Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vasily Isakov, Marlen I. Castellanos Fernández, Vincent Wai-Sun Wong, Yuichiro Eguchi, Manuel Romero-Gómez, Nahum Méndez-Sánchez, Ajay K. Duseja, Caglayan Keklikkiran, Jacob George, Elisabetta Bugianesi, Ashwani K. Singal, Saeed S. Hamid, Khalid A. Alswat, Wah-Kheong Chan, Jiangao Fan, George Papatheodoridis, Stuart C. Gordon, Mohamed El-Kassas, Stuart Roberts, Brian Lam, Andrei Racila, Linda Henry, Saleh Alqahtani, and Maria Stepanova
Long-term efficacy and safety of open-label seladelpar treatment in patients with primary biliary cholangitis (PBC): interimresults for 2 years from the ASSURE study
Palak J. Trivedi, Cynthia Levy, Kris V. Kowdley, Stuart C. Gordon, Christopher L. Bowlus, María C. Londoño, Gideon M. Hirschfield, Aliya Gulamhusein, Eric Lawitz, Alejandra Villamil, Alma L. Ladrón de Guevara, Marlyn J. Mayo, Ziad H. Younes, Oren Shibolet, Kidist Yimam, Daniel Pratt, Jeong Heo, Ulrike Morgera, Pietro Andreone, Andreas E. Kremer, Christophe Corpechot, Aparna Goel, Adam Peyton, Hany Elbeshbeshy, Daria B. Crittenden, Carrie Heusner, Sarah Proehl, Shuqiong Zhou, and Charles A. McWherter
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival in an international multicentre cohort
Vincenzo Ronca, Alessandro Parente, Ellina Lytvyak, Bettina Hansen, Gideon M. Hirschfield, Alan Bonder, Maryam Ebadi, Saleh Elwir, Mohamad Alsaed, Piotr Milkiewicz, Maciej Janik, Hanns-Ulrich Marschall, Maria A. Burza, Cumali Efe, Ali R. Caliskan, Murat Harputluoglu, Gökhan Kabaçam, Debora R. Terrabuio, Fernanda Onofrio, Nazia Selzner, Albert Pares, Laura P. Llovet, Murat Akyildiz, Cigdem Arıkan, Michael P. Manns, Richard Taubert, Anna-Lena Weber, Thomas Schiano, Brandy Haydel, and Piotr Czubkowski
Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies
Stuart C. Gordon, Palak Trivedi, Christopher Bowlus, Galambos Michael, Aparna Goel, Aliya Gulamhusein, Cynthia Levy, Guy Neff, Carmen Stanca, Douglas Thorburn, Bruce Bacon, Brian Borg, Yvonne Doerffel, Lisa Forman, Bradley Freilich, Liana Gheorghe, María S. González, Stephen Harrison, Jonathan Huang, Sook-Hyang Jeong, Seung U. Kim, John Lake, Joseph Odin, Won Y. Tak, Hillel Tobias, John M. Vierling, Ke Yang, Alexandra Steinberg, Yun-Jung Choi, and Charles McWherter
Efficacy and safety of seladelpar in patients with primary biliary cholangitis and compensated liver cirrhosis in the open-label long-term ASSURE safety study: interim results
Stuart C. Gordon, Ira Jacobson, Ziad H. Younes, Marina Silveira, Joost P. H Drenth, Ulrike Morgera, George Dalekos, Jeong Heo, Ke Yang, Carrie Heusner, Daria B. Crittenden, and Charles A. McWherter
Novel Use of a Biologic Agent for an Uncommon Complication of an Old Surgery: Successful Use of Ustekinumab for Kock Pouchitis
William Davis, Mohammed Abusuliman, and Najwa El-Nachef
FRI-030 In patients with metabolic dysfunction-associated steatotic liver disease, sleep disturbance is highly prevalent and associated with a profound impairment of health-related quality of life
Zobair Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El-Kassas, Marlen I. Castellanos Fernández, Yuichiro Eguchi, George Papatheodoridis, Vincent Wai-Sun Wong, Ajay K. Duseja, Ashwani K. Singal, Saeed S. Hamid, Elisabetta Bugianesi, Vasily Isakov, Manuel Romero-Gómez, Wah-Kheong Chan, Khalid A. Alswat, Jiangao Fan, and Stuart C. Gordon
Patterns of transaminase elevation in patients on TPN and association with mortality
Bipneet Singh, Spandana Alluri, Sruthi Ramanan, and Merritt Bern
Unseen burden: Emotional, financial and occupational impacts on caregivers of patients with short bowel syndrome
M. F. Winkler, J. E. Harrison, R. Vemulapalli, V. Kumpf, G. Mitchell, D. Wolin, L. Zografos, M. Yang, L. Jackson, J. Wang, J. Henderson, M. Boules, and Syed-Mohammed Jafri
Complications of TPN in cirrhotic population
Bipneet Singh, Spandana Alluri, and Sruthi Ramanan
Reducing parenteral support: patient and healthcare professional preferences for potential new short bowel syndrome therapies
Syed-Mohammed Jafri, J. E. Harrison, V. Kumpf, G. Mitchell, D. Wolin, L. Zografos, M. Yang, L. Jackson, J. Wang, J. Henderson, M. Boules, and R. Vemulapalli
Beyond the diagnosis: The socioeconomic burden of SBS patients dependent on parenteral support
J. E. Harrison, Syed-Mohammed Jafri, R. Vemulapalli, G. Mitchell, D. Wolin, L. Zografos, M. Yang, L. Jackson, J. Wang, J. Henderson, M. Boules, and V. Kumpf
*Updated as of 12/18/25.
